A new drug may reduce inflammation and atherosclerosis
Patients at high risk of recurrences of heart disease: Breakthrough in prevention – A clinical study directed by Dr. Jean-Claude Tardif of the Montreal Heart Institute confirms the potential of a medication to reduce inflammation in patients with atherosclerosis.